Jim Simons Medical Devices

Renaissance Technologies LLC

$62.3 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
EW Edwards Lifesciences Corp	$49.5B	$73 Million 0.12% of portfolio	1,006,600	Q1 2025 Added 54.27%
BSX Boston Scientific Corp	$152B	$65.7 Million 0.11% of portfolio	651,553	Q1 2025 New
UFPT Ufp Technologies Inc	$1.79B	$52.4 Million 0.08% of portfolio	259,659	Q1 2025 Reduced 6.99%
DXCM Dexcom Inc	$34.4B	$43.1 Million 0.07% of portfolio	630,774	Q1 2025 Reduced 29.12%
PODD Insulet Corp	$20.1B	$41.8 Million 0.07% of portfolio	159,193	Q1 2025 Added 0.13%
INMD In Mode Ltd.	$1.21B	$40.9 Million 0.07% of portfolio	2,306,918	Q1 2025 Added 1.78%
INSP Inspire Medical Systems, Inc.	$3.7B	$30.4 Million 0.05% of portfolio	190,700	Q1 2025 Added 39.5%
IRMD Iradimed Corp	$711M	$26.3 Million 0.04% of portfolio	501,712	Q1 2025 Reduced 2.2%
PRCT Procept Bio Robotics Corp	$2.61B	$18.3 Million 0.03% of portfolio	314,466	Q1 2025 Added 12.93%
GMED Globus Medical Inc	$4.11B	$13 Million 0.02% of portfolio	176,918	Q1 2025 New
BRKR Bruker Corp	$6.21B	$11.8 Million 0.02% of portfolio	283,710	Q1 2025 New
RXST Rx Sight, Inc.	$219M	$11.4 Million 0.02% of portfolio	451,600	Q1 2025 Added 24.92%
ANIK Anika Therapeutics, Inc.	$165M	$7.95 Million 0.01% of portfolio	528,617	Q1 2025 Added 0.02%
NVRO Nevro Corp	$207M	$7.06 Million 0.01% of portfolio	1,209,409	Q1 2025 Added 302.72%
TNDM Tandem Diabetes Care Inc	$992M	$5.48 Million 0.01% of portfolio	286,127	Q1 2025 Reduced 9.38%
INGN Inogen Inc	$155M	$5.21 Million 0.01% of portfolio	730,800	Q1 2025 Added 48.27%
BVS Bioventus Inc.	$395M	$5.06 Million 0.01% of portfolio	553,500	Q1 2025 Added 42.4%
ARAY Accuray Inc	$129M	$4.87 Million 0.01% of portfolio	2,723,384	Q1 2025 Reduced 8.61%
TCMD Tactile Systems Technology Inc	$206M	$4.81 Million 0.01% of portfolio	364,100	Q1 2025 Reduced 19.29%
AHCO Adapt Health Corp.	$1.24B	$4.47 Million 0.01% of portfolio	412,365	Q1 2025 New
LNSR Lensar, Inc.	$144M	$4.43 Million 0.01% of portfolio	313,645	Q1 2025 Reduced 10.1%
FONR Fonar Corp	$105M	$4.26 Million 0.01% of portfolio	304,416	Q1 2025 Reduced 2.96%
ZIMV Zim Vie Inc.	$488M	$3.89 Million 0.01% of portfolio	360,000	Q1 2025 Added 1.04%
ELMD Electromed, Inc.	$157M	$3.61 Million 0.01% of portfolio	151,304	Q1 2025 Added 27.86%
VREX Varex Imaging Corp	$301M	$3.58 Million 0.01% of portfolio	308,700	Q1 2025 Added 18.87%
SENS Senseonics Holdings, Inc.	$265M	$3.12 Million 0.01% of portfolio	4,726,559	Q1 2025 Added 243.49%
SIBN Si Bone, Inc.	$596M	$2.99 Million 0.0% of portfolio	213,100	Q1 2025 Added 91.29%
BWAY Brainsway Ltd.	$194M	$2.82 Million 0.0% of portfolio	298,260	Q1 2025 Reduced 9.52%
VMD Viemed Healthcare, Inc.	$240M	$2.8 Million 0.0% of portfolio	384,400	Q1 2025 Added 3.06%
CTKB Cytek Biosciences, Inc.	$448M	$2.76 Million 0.0% of portfolio	687,600	Q1 2025 Added 48.64%
IRTC I Rhythm Technologies, Inc.	$3.97B	$2.31 Million 0.0% of portfolio	22,100	Q1 2025 New
ATEC Alphatec Holdings, Inc.	$1.12B	$2.19 Million 0.0% of portfolio	216,468	Q1 2025 Reduced 25.89%
LIVN Liva Nova PLC	$2.32B	$2.03 Million 0.0% of portfolio	51,694	Q1 2025 Reduced 54.09%
NPCE Neuro Pace Inc	$223M	$1.91 Million 0.0% of portfolio	155,800	Q1 2025 Added 80.53%
CERS Cerus Corp	$241M	$1.9 Million 0.0% of portfolio	1,369,400	Q1 2025 Added 229.49%
OFIX Orthofix Medical Inc.	$225M	$1.5 Million 0.0% of portfolio	91,990	Q1 2025 Added 11.92%
SGHT Sight Sciences, Inc.	$170M	$1.46 Million 0.0% of portfolio	607,277	Q1 2025 Added 54.52%
ICAD Icad Inc	$98M	$1.35 Million 0.0% of portfolio	655,990	Q1 2025 Added 37.93%
QTRX Quanterix Corp	$204M	$1.32 Million 0.0% of portfolio	202,921	Q1 2025 Added 243.35%
SRTS Sensus Healthcare, Inc.	$91.2M	$1.23 Million 0.0% of portfolio	259,634	Q1 2025 Reduced 39.75%
AXGN Axogen, Inc.	$559M	$1.15 Million 0.0% of portfolio	62,000	Q1 2025 Added 181.82%
LUNG Pulmonx Corp	$124M	$1.11 Million 0.0% of portfolio	165,300	Q1 2025 Reduced 25.04%
TMCI Treace Medical Concepts, Inc.	$321M	$1.06 Million 0.0% of portfolio	126,800	Q1 2025 Added 13.21%
MXCT Maxcyte, Inc.	$231M	$1 Million 0.0% of portfolio	367,900	Q1 2025 Added 30.83%
BFLY Butterfly Network, Inc.	$360M	$948,000 0.0% of portfolio	416,200	Q1 2025 Reduced 58.43%
DCTH Delcath Systems, Inc.	$96.6M	$907,000 0.0% of portfolio	71,300	Q1 2025 Reduced 48.42%
LUCD Lucid Diagnostics Inc.	$41.7M	$684,000 0.0% of portfolio	459,065	Q1 2025 New
MASS 908 Devices Inc.	$233M	$647,000 0.0% of portfolio	144,600	Q1 2025 Reduced 50.98%
CLPT Clear Point Neuro, Inc.	$276M	$606,000 0.0% of portfolio	51,000	Q1 2025 New
QIPT Quipt Home Medical Corp.	$75.4M	$569,000 0.0% of portfolio	244,600	Q1 2025 Added 6.53%

Shares Options

Jim Simons

Jim Simons is the founder and chairman of Renaissance Technologies, a successful investment firm that uses quantitative approaches to investing. Simons is known for his expertise in mathematical modeling and has a reputation for being a skilled and successful investor. He has generated strong returns for his clients over the long term.

Track Jim Simons's portfolio

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account